Clinical Trial Update: Copper Histidinate Treatment for Menkes Disease

View source ↗

Summary

Copper histidinate has been approved for marketing to treat Menkes disease.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Menkes Disease

Drugs mentioned

• Copper histidinate (copper histidinate)

Snippet

Sponsor: Sentynl Therapeutics, Inc. | Conditions: Menkes Disease | Status: APPROVED_FOR_MARKETING